Credo Technology stock surged roughly 15% on April 13 after Jefferies initiated coverage with a Buy rating and a $175 price ...
Strong Q1Expecting sequential acceleration in Q2Confirming full year guidance despite macro contextApril 14, 2026Revenue ...
Seaport Therapeutics’ IPO aims to fund prodrug R&D for neuropsychiatric disorders. Read the full analysis here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results